Weight Management

Empagliflozin and linagliptin (Glyxambi) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Results of studies show that women with obesity who get these weight loss procedures often also have preventative benefits.

Ozempic is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Increasing physical activities and reducing caloric intake isn’t always enough to conquer obesity.

New study results show that rapidly adding pounds in the first and final months of gestation likely plays a key role in the development of excess fat tissue in female children and adolescents.

Even after taking cardiovascular risks or vascular brain injury into account, the association remained, study results show.

Limited empirical data from new study suggests correlations between obesity and individual SDOH, such as education level, food environment, income, and neighborhood.

Investigators found that an additional hour of sleep correlated with a 26% decrease in an infant’s risk of being overweight.

Pharmacists can help to reduce the prevalence of food insecurity and its negative health care outcomes by tailoring clinical care to each individual patient’s needs.

Marinol is a cannabinoid indicated for anorexia associated with weight loss in patients with AIDS.

Obesity, high blood pressure, and diabetes were the most common comorbidities.

An embryonic stem cell model allowed investigators to study the genetic architecture first in hypothalamic progenitor cells, prior to their full development, and then nucleus-like hypothalamic neurons.

Almost 80% of individuals with type 2 diabetes lost more than 22 pounds and maintained that weight loss in remission for at least 2 years, study results show.

Individuals treated with Wegovy who are obese are overweight are more likely to lose at least 5% of their body weight compared with the placebo.

This weight loss can prevent the onset of type 2 diabetes for new mothers.

They are attempting to determine the associations and connections to further benefit individuals using the therapies.

Dumping syndrome occurs when food, especially sugar, moves from the stomach into the small bowel too quickly.

Having community pharmacists to influence outcomes associated with social determinants of health in the US population is vital to improving overall patient outcomes.

Patients with bulimia may use different methods to get rid of calories and prevent weight gain, such as self-inducing vomiting on a regular basis.

Semaglutide acts as a GLP-1 receptor agonist that selectively binds to and activates the GLP-1 receptor.

The researchers also demonstrated that ketone supplements may be a novel therapy for protecting and improving brain health in people with obesity who are at risk of developing neurocognitive impairment.

The national guidelines recommend a heart-healthy diet to help manage weight and control blood pressure, while also emphasizing dietary patterns rather than individual foods and nutrients.

Semaglutide (Rybelsus) is a glucagon-like peptide-1 receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Study shows that shedding pounds potentially decreases the risk of diabetes, dyslipidemia, and high blood pressure.

Surgical procedures and weight-loss drugs combat high hypertension in individuals who are obese or overweight, according to the American Heart Association.

Guidance on the use of basal insulins (BI) and insulin pens to enable pharmacists to answer questions regarding the safe and effective use of BI for the management of diabetes.

Compared to women who followed the Portfolio Diet less frequently, those with the closest alignment were 11% less likely to develop any type of cardiovascular disease, 14% less likely to develop coronary heart disease, and 17% less likely to develop heart failure.

In addition to early screening, counseling patients on preventive interventions can reduce the risk of developing prediabetes or type 2 diabetes.

Additionally, among this population, combining aerobic exercise with a moderate reduction in daily calories resulted in greater improvements in aortic stiffness versus exercise only or exercise plus a more restrictive diet.

Semaglutide is a once weekly subcutaneous injection that was granted FDA approval for use in adults with obesity or overweight with at least one other weight related-condition.